• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国西北银川市非药物 COVID-19 控制措施对其他传染病的间接影响:一项时间序列研究。

The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.

机构信息

School of Public Health, Ningxia Medical University, Yinchuan, 750004, Ningxia, China.

Key Laboratory of Environmental Factors and Chronic Disease Control, No. 1160, Shengli Street, Xingqing District, Yinchuan, 750004, Ningxia, China.

出版信息

BMC Public Health. 2023 Jun 6;23(1):1089. doi: 10.1186/s12889-023-15878-3.

DOI:10.1186/s12889-023-15878-3
PMID:37280569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10242608/
Abstract

BACKGROUND

Various nonpharmaceutical interventions (NPIs) against COVID-19 continue to have an impact on socioeconomic and population behaviour patterns. However, the effect of NPIs on notifiable infectious diseases remains inconclusive due to the variability of the disease spectrum, high-incidence endemic diseases and environmental factors across different geographical regions. Thus, it is of public health interest to explore the influence of NPIs on notifiable infectious diseases in Yinchuan, Northwest China.

METHODS

Based on data on notifiable infectious diseases (NIDs), air pollutants, meteorological data, and the number of health institutional personnel in Yinchuan, we first fitted dynamic regression time series models to the incidence of NIDs from 2013 to 2019 and then estimated the incidence for 2020. Then, we compared the projected time series data with the observed incidence of NIDs in 2020. We calculated the relative reduction in NIDs at different emergency response levels in 2020 to identify the impacts of NIPs on NIDs in Yinchuan.

RESULTS

A total of 15,711 cases of NIDs were reported in Yinchuan in 2020, which was 42.59% lower than the average annual number of cases from 2013 to 2019. Natural focal diseases and vector-borne infectious diseases showed an increasing trend, as the observed incidence in 2020 was 46.86% higher than the estimated cases. The observed number of cases changed in respiratory infectious diseases, intestinal infectious diseases and sexually transmitted or bloodborne diseases were 65.27%, 58.45% and 35.01% higher than the expected number, respectively. The NIDs with the highest reductions in each subgroup were hand, foot, and mouth disease (5854 cases), infectious diarrhoea (2157 cases) and scarlet fever (832 cases), respectively. In addition, it was also found that the expected relative reduction in NIDs in 2020 showed a decline across different emergency response levels, as the relative reduction dropped from 65.65% (95% CI: -65.86%, 80.84%) during the level 1 response to 52.72% (95% CI: 20.84%, 66.30%) during the level 3 response.

CONCLUSIONS

The widespread implementation of NPIs in 2020 may have had significant inhibitory effects on the incidence of respiratory infectious diseases, intestinal infectious diseases and sexually transmitted or bloodborne diseases. The relative reduction in NIDs during different emergency response levels in 2020 showed a declining trend as the response level changed from level 1 to level 3. These results can serve as essential guidance for policy-makers and stakeholders to take specific actions to control infectious diseases and protect vulnerable populations in the future.

摘要

背景

针对 COVID-19 的各种非药物干预(NPIs)继续对社会经济和人口行为模式产生影响。然而,由于疾病谱的可变性、高发地方性疾病和不同地理区域的环境因素,NPIs 对法定传染病的影响仍不确定。因此,探索 NPIs 对中国西北银川市法定传染病的影响具有公共卫生意义。

方法

基于银川市法定传染病(NIDs)、空气污染物、气象数据和卫生机构人员数量的数据,我们首先拟合了 2013 年至 2019 年 NIDs 的动态回归时间序列模型,然后估计了 2020 年的发病率。然后,我们将预测的时间序列数据与 2020 年 NIDs 的实际发病率进行了比较。我们计算了 2020 年不同应急响应级别下 NIDs 的相对减少量,以确定 NPIs 对银川市 NIDs 的影响。

结果

2020 年银川市共报告法定传染病 15711 例,比 2013 年至 2019 年的年平均病例数减少 42.59%。自然焦点疾病和虫媒传染病呈上升趋势,2020 年实际发病率比预测病例高 46.86%。呼吸道传染病、肠道传染病和性传播或血源传染病的实际病例数分别比预期病例数高出 65.27%、58.45%和 35.01%。每个亚组中 NIDs 减少最多的是手足口病(5854 例)、传染性腹泻(2157 例)和猩红热(832 例)。此外,还发现 2020 年不同应急响应级别下预期的 NIDs 相对减少量呈下降趋势,因为相对减少量从 1 级响应时的 65.65%(95%CI:-65.86%,80.84%)下降到 3 级响应时的 52.72%(95%CI:20.84%,66.30%)。

结论

2020 年广泛实施 NPIs 可能对呼吸道传染病、肠道传染病和性传播或血源传染病的发病率产生了显著的抑制作用。2020 年不同应急响应级别下 NIDs 的相对减少量呈下降趋势,应急响应级别从 1 级变为 3 级。这些结果可为决策者和利益相关者提供重要指导,以便他们在未来采取具体行动控制传染病并保护弱势群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/84172556767a/12889_2023_15878_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/c9f1e36cc9f8/12889_2023_15878_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/c21276709040/12889_2023_15878_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/af7cc34426be/12889_2023_15878_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/d9e26f66b487/12889_2023_15878_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/84172556767a/12889_2023_15878_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/c9f1e36cc9f8/12889_2023_15878_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/c21276709040/12889_2023_15878_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/af7cc34426be/12889_2023_15878_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/d9e26f66b487/12889_2023_15878_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13e/10242806/84172556767a/12889_2023_15878_Fig5_HTML.jpg

相似文献

1
The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.中国西北银川市非药物 COVID-19 控制措施对其他传染病的间接影响:一项时间序列研究。
BMC Public Health. 2023 Jun 6;23(1):1089. doi: 10.1186/s12889-023-15878-3.
2
Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study.中国非药物干预措施对新冠疫情及其他传染病的协同效益:一项基于大规模人群的观察性研究。
Lancet Reg Health West Pac. 2021 Dec;17:100282. doi: 10.1016/j.lanwpc.2021.100282. Epub 2021 Oct 1.
3
Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.中国 COVID-19 大流行前后 24 种法定传染病的时间变化。
Nat Commun. 2024 May 8;15(1):3891. doi: 10.1038/s41467-024-48201-8.
4
Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.COVID-19 限制措施对中国法定传染病谱的间接影响的持续性和变化:2018 年至 2021 年对儿童和青少年进行的全国监测分析。
JMIR Public Health Surveill. 2024 May 15;10:e47626. doi: 10.2196/47626.
5
Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.中国 COVID-19 大流行期间传染病报告发病率的变化。
Nat Commun. 2021 Nov 26;12(1):6923. doi: 10.1038/s41467-021-27292-7.
6
Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.中国在 COVID-19 防控措施下传染病报告发病率的变化。
Front Public Health. 2021 Oct 15;9:728768. doi: 10.3389/fpubh.2021.728768. eCollection 2021.
7
Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.中国 44 种法定传染病的流行趋势和差异:基于 2010 年至 2019 年国家监测数据的分析。
J Med Virol. 2023 Jan;95(1):e28353. doi: 10.1002/jmv.28353.
8
The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study.COVID-19 对台湾非空气传播/飞沫传播传染病流行病学的影响:描述性研究。
J Infect Public Health. 2022 Sep;15(9):1001-1005. doi: 10.1016/j.jiph.2022.08.001. Epub 2022 Aug 4.
9
The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China.抗新冠病毒非药物干预措施对中国西北部西安市手足口病的影响:时空视角。
J Med Virol. 2022 Jul;94(7):3121-3132. doi: 10.1002/jmv.27715. Epub 2022 Mar 22.
10
Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China.利用 ARIMA 模型的中断时间序列分析 COVID-19 对中国法定传染病发病率的影响。
BMC Infect Dis. 2023 Jun 5;23(1):375. doi: 10.1186/s12879-023-08229-5.

引用本文的文献

1
Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.中国 COVID-19 大流行前后 24 种法定传染病的时间变化。
Nat Commun. 2024 May 8;15(1):3891. doi: 10.1038/s41467-024-48201-8.
2
Heterogeneity of influenza infection at precise scale in Yinchuan, Northwest China, 2012-2022: evidence from Joinpoint regression and spatiotemporal analysis.2012-2022 年中国西北银川流感感染的精确尺度异质性:来自 Joinpoint 回归和时空分析的证据。
Sci Rep. 2024 Feb 6;14(1):3079. doi: 10.1038/s41598-024-53767-w.
3
Evaluating the long-term impact of COVID-19-associated public health interventions on zoonotic and vector-borne diseases in China: an interrupted time series analysis.

本文引用的文献

1
Comparison of 19 major infectious diseases during COVID-19 epidemic and previous years in Zhejiang, implications for prevention measures.比较 COVID-19 疫情期间与往年在浙江的 19 种主要传染病,对预防措施的启示。
BMC Infect Dis. 2022 Mar 28;22(1):296. doi: 10.1186/s12879-022-07301-w.
2
Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China.2019年冠状病毒病防控措施对中国大陆手足口病发病率的影响
Lancet Reg Health West Pac. 2022 Mar;20:100362. doi: 10.1016/j.lanwpc.2021.100362. Epub 2022 Jan 1.
3
The impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China.
评估 COVID-19 相关公共卫生干预措施对中国动物源性和媒介传播疾病的长期影响:一项中断时间序列分析。
J Transl Med. 2024 Jan 20;22(1):81. doi: 10.1186/s12967-024-04855-y.
COVID-19 大流行对中国人畜共患疾病发病率和死亡率的影响。
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-007109.
4
The Epidemic of Sexually Transmitted Diseases Under the Influence of COVID-19 in China.中国 COVID-19 疫情下性传播疾病的流行。
Front Public Health. 2021 Dec 16;9:737817. doi: 10.3389/fpubh.2021.737817. eCollection 2021.
5
Public Health Measures During the COVID-19 Pandemic Reduce the Spread of Other Respiratory Infectious Diseases.在 COVID-19 大流行期间采取的公共卫生措施可减少其他呼吸道传染病的传播。
Front Public Health. 2021 Nov 10;9:771638. doi: 10.3389/fpubh.2021.771638. eCollection 2021.
6
What can the world learn from China's response to covid-19?中国应对新冠疫情的经验对世界有何启示?
BMJ. 2021 Dec 1;375:n2806. doi: 10.1136/bmj.n2806.
7
Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.中国 COVID-19 大流行期间传染病报告发病率的变化。
Nat Commun. 2021 Nov 26;12(1):6923. doi: 10.1038/s41467-021-27292-7.
8
Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study.中国非药物干预措施对新冠疫情及其他传染病的协同效益:一项基于大规模人群的观察性研究。
Lancet Reg Health West Pac. 2021 Dec;17:100282. doi: 10.1016/j.lanwpc.2021.100282. Epub 2021 Oct 1.
9
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
10
Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020.2019冠状病毒病大流行及相关非药物干预措施对德国其他法定传染病的影响:2016年第1周 - 2020年第32周国家监测数据分析
Lancet Reg Health Eur. 2021 Jun 19;6:100103. doi: 10.1016/j.lanepe.2021.100103. eCollection 2021 Jul.